In a regulatory filing, Brazilian medical lab company Fleury SA said, a cyberattack had resulted in the partial outage of its information technology systems.

The company is assessing the impact of the cyberattack and is taking actions to minimize its effects. It would inform the market in a timely manner regarding any relevant updates on the situation.